<ѻý>Andexanet Holds Strong as Antidote to Apixaban, Rivaroxabanѻý> Reversal agent for factor Xa inhibitors soon to be subject to a randomized trial Feb 08, 2019
<ѻý>Trump's Health: Excellent or 'Ticking Bomb'?ѻý> Zero publicly reported medical events in first 2 years in office Feb 07, 2019
<ѻý>Heavy Workouts Linked to Hard Arteriesѻý> But subclinical calcified plaque didn't translate into mortality risk in study Jan 30, 2019
<ѻý>Tweet This! Savvy Twitter Usage Linked to Bigger Research Profilesѻý> Social media engagement may boost citation indexes, or vice versa Jan 28, 2019
<ѻý>Vaginal Estrogen Not Tied to Added Heart, Cancer Risksѻý> Study looked at 18 years of data on postmenopausal women Dec 20, 2018
<ѻý>Visual Guide to AVERT's VTE Prevention in Cancerѻý> Apixaban effective against important chemotherapy side effect Dec 07, 2018
<ѻý>Cancer-VTE Trial Falls Shortѻý> High dropout rate undermines rivaroxaban prophylaxis trial Dec 05, 2018
<ѻý>The Most Wonderful Mistake the FDA Ever Madeѻý> Milton Packer explains how an FDA error enlightened the practice of medicine Dec 05, 2018
<ѻý>FDA OKs Heart Disease Prevention Claim for High Oleic Acid Oilsѻý> Olive oil and certain other vegetable, seed oils get qualified health claim Nov 19, 2018
<ѻý>Omega-3 and Vitamin D; Vein Grafts and CABG: It's PodMed Double T!ѻý> This week's topics include benefits of CABG, vein harvesting, new exercise guidelines, and omega-3 and vitamin D supplementation Nov 17, 2018 podcast
<ѻý>Metabolic Surgery Prevails for Mortality, CV-Risk Reduction in T2Dѻý> Macrovascular complications, CV mortality reduced more with surgery than medical therapy alone Nov 15, 2018
<ѻý>National Exercise Guidelines Now Say 'Just Move'ѻý> HHS recs say to sit less, move more to improve health outcomes Nov 12, 2018
<ѻý>AHA: Rivaroxaban May Cut Thromboembolic Risk in HF Patientsѻý> Post hoc analysis of COMMANDER HF trial suggestive of benefit Nov 11, 2018 video
<ѻý>AHA: Zetia May Cut CV Events in Japanese Seniorsѻý> Results from EWTOPIA75 trial not enough to change practice, experts says Nov 11, 2018
<ѻý>AHA: In-hospital Entresto Safe, Beneficial in HFrEFѻý> PIONEER-HF shows improved biomarkers and possibly outcomes too Nov 11, 2018 video
<ѻý>AHA: Fish Oil, Vitamin D Not VITAL to Heart Healthѻý> VITAL trial also showed no benefits for cancer incidence with both supplements Nov 10, 2018 video
<ѻý>AHA: Targeting Inflammation With Methotrexate Flops for CV Preventionѻý> CIRT trial disappoints after CANTOS' win for the inflammatory hypothesis Nov 10, 2018 video
<ѻý>AHA: Prescription Fish Oil Wins for CV Preventionѻý> Positive findings for Vascepa in REDUCE-IT trial Nov 10, 2018 video
<ѻý>AHA: Revised Lipid Guide Boosts PCSK9s, Coronary Calcium Scansѻý> New recommendations aim to cut statins in low-risk primary prevention Nov 10, 2018 video
<ѻý>Heart Benefit with Dulaglutide; New Hot Flash Therapy; Diabetes Risks in Womenѻý> News and commentary from the endocrinology world Nov 09, 2018
<ѻý>AHA: Lipid Guidelines to Headline Meetingѻý> Exercise, fish oil, Entresto in acute HF, and an anti-inflammatory also in the spotlight Nov 08, 2018
<ѻý>AHA: Late Meals Linked to HTN, Prediabetesѻý> Risks seen in study of Hispanic and Latino Americans Nov 06, 2018
<ѻý>Expert Panel: Cap Oxygen Saturation at 96% for Acutely Ill Patientsѻý> Recommends special caution for stroke, MI patients Oct 25, 2018
<ѻý>Case Study: Influenza Turned Lethalѻý> Fulminant myocarditis claims life of otherwise healthy child Oct 22, 2018
<ѻý>FDA Rejects Canakinumab in CVD Preventionѻý> CANTOS data not enough to expand indication Oct 19, 2018
<ѻý>Morning Break: Human Side of Addiction; Eyeing Da Vinci's Genius; No CV Indication for Ilarisѻý> Health news and commentary from around the Web gathered by the ѻý staff Oct 19, 2018
<ѻý>The Rest of the Story on Vitamin B for Stroke Preventionѻý> J. David Spence, MD, digs into the developing rationale for a different kind of B Oct 17, 2018
<ѻý>FDA Approves Rivaroxaban for CV Prevention in CAD, PADѻý> Low dose to arrive in the U.S. next week Oct 12, 2018
<ѻý>NSAIDs OK for Certain High-Risk Groups?ѻý> No obvious harm seen in HTN, HF, or chronic kidney disease Oct 08, 2018
<ѻý>Sandeep Jauhar's Real-Life Tales From, and of, the Heartѻý> Exploring the organ's intertwined metaphorical and biological aspects Oct 08, 2018
<ѻý>Withdrawn Diabetes Drug Worked in Secondary CV Preventionѻý> Large cardiovascular outcomes trial showed a particular reduction in MI Oct 05, 2018
<ѻý>Heart Benefit Seen with GLP-1 RA Albiglutideѻý> Significant reduction in myocardial infarctions; will drug be brought back to market? Oct 02, 2018
<ѻý>TCT: Near-Infrared Spectroscopy IDs Plaques Likely to Cause Problemsѻý> Non-culprit lesions with large lipid core associated with events Sep 24, 2018
<ѻý>TCT: Stopping Antiplatelets 1 Year Post-Stent Risky for Afib Patients?ѻý> Underpowered trial suggested oral anticoagulation alone isn't enough Sep 24, 2018
<ѻý>Vascepa Prevents Major Cardiovascular Events, Says Manufacturerѻý> Big win for proprietary fish-oil product Sep 24, 2018
<ѻý>TCT: Femoropopliteal Stents On Par in First Head-to-Head Trialѻý> Primary patency, major adverse events at least as good with Eluvia as Zilver PTX Sep 22, 2018
<ѻý>Macitentan Shows Promise in Portopulmonary Hypertensionѻý> Positive results in first randomized trial in the disease Sep 20, 2018
<ѻý>Controlling BP Variability May Be Key to ICH Outcomesѻý> Aggressive BP reduction alone has failed in the past Sep 07, 2018
<ѻý>Aspirin, Fish Oil Disappoint in Primary CV Preventionѻý> Two randomized trials suggest little to no net benefit Aug 31, 2018
<ѻý>ESC: PURE Buries Controversy, Advocates for 'Balanced Diet'ѻý> But dairy and red meat levels still differ from guidelines Aug 28, 2018